Phase II study of pemetrexed and carboplatin plus bevacizumab as first-line therapy in malignant pleural mesotheliomaCERESOLI, G. L; ZUCALI, P. A; SOTO-PARRA, H et al.British journal of cancer. 2013, Vol 109, Num 3, pp 552-558, issn 0007-0920, 7 p.Article

Prognostic factors in elderly patients with malignant pleural mesothelioma: results of a multicenter surveyCERESOLI, G. L; GROSSO, F; PICCOLINI, E et al.British journal of cancer. 2014, Vol 111, Num 2, pp 220-226, issn 0007-0920, 7 p.Article